Dr Vanessa Sancho-Shimizu (a UKRI Future Leaders Fellow and Reader in the sections of Paediatrics Infectious Diseases and Virology investigating the human genetic basis of life-threatening infections) in a lab environment. She is wearing safety glasses and a white lab coat.

✨We’re looking for up to 20 new non-clinical Assistant Professors to join our world-class academic community.💫

Could that be you?

Find out more and apply by 11 March 2026: www.imperial.ac.uk/jobs/search-...

It brings together in one place for the first time the most amazing grouping of infection researchers within NIHR Biomedical Research Centres and other centres of excellence. Great opportunities to support plans for the NHS and life sciences in England and beyond

Delighted that, with @stat-sarah.bsky.social and @nihr.bsky.social colleagues, we formally launched the new Translational Research Collaboration in Infection and AMR this week.

tinyurl.com/5cdbee8k

Blue graphic with white text: Head of the Department of Infectious Disease. Recruiting now: Apply by 15 September.

We’re looking for an exceptional academic leader with a compelling vision to Head @imperialinfect.bsky.social at @imperialcollegeldn.bsky.social.

Apply by 15 September 2025

With thanks to all our SEARCH collaborators at Hospital for Tropical Diseases (HCMC), National Hospital for Tropical Disease (Hanoi), @ox.ac.uk /OUCRU , MRC CTU and MORU (Bangkok)

Taken together these findings should provide key information to all those looking to eliminate hepatitis including patients and their carers, policy makers and those running services

These included (i) which are the most effective of the first line treatments recommended by WHO and (ii) are there novel strategies that can cure infection that might allow reduced pill burden, shorter duration and/or be suitable for treating hard to reach groups?

The innovative trial design allowed us to provide clear answers to a number of key questions around hepatitis C treatment

The trial is the cornerstone a 10-year programme supported by @wellcometrust.bsky.social (building on initial Medical Research Council ODA funding) looking at questions ranging from fundamental biology and clinical science to economic evaluation and community engagement.

Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial Sofosbuvir–daclatasvir was non-inferior to sofosbuvir–velpatasvir. High efficacy was seen with novel strategies, which might help to inform approaches to treatment for harder-to-reach populations.

The results from our VIETnarms trial are out in this week’s @thelancet.bsky.social , www.thelancet.com/journals/lan... with an accompanying editorial www.thelancet.com/journals/lan....

‘Exodus’ of clinical researchers sparks concern over future of UK healthcare Lack of incentives is driving down the number of clinical researchers in Britain

Is an ‘exodus’ of clinical researchers threatening the future of UK healthcare?

“For young NHS clinicians coming through they are often not rewarded for what they’ve done in science whereas they used to be." – Prof Graham Cooke spoke to @financialtimes.com

www.ft.com/content/c4fa...

Decoding viruses and defying limits: Professor Wendy Barclay appointed Regius Professor A life dedicated to understanding viruses with pandemic potential

A scientist. A leader. A mentor. 👩‍🔬🌟

Professor Wendy Barclay becomes @imperialcollegeldn.bsky.social's first female Regius Professor of Infectious Disease—recognised for her pioneering research and global impact. 🎉

Discover her story ⤵️ www.imperial.ac.uk/stories/Wend... #WomenInSTEM

Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’ The British scientist on the risk of humans contracting bird flu, how people would cope with new lockdowns and being asked to pour the tea because she is a woman

Should we worry about a growing threat from bird flu? 🐦

Imperial’s Wendy Barclay, Head of @imperialinfect.bsky.social spoke to @theguardian.com about her research into how the virus is evolving.

Read more ⬇️
www.theguardian.com/science/2025...

@imperialmed.bsky.social

Personalising risk from COVID-19 key to protecting immunosuppressed people | Imperial News | Imperial College London New research underscores the need for ongoing COVID-19 protection for people with weakened immune systems.

A simple blood test could transform #COVID19 care for immunosuppressed people. 🩸

New findings published in @thelancet.bsky.social reveal how personalised approaches to #vaccination can protect those most at risk.

Read more ⤵️ www.imperial.ac.uk/news/260173/... @imperialcollegeldn.bsky.social

Late abstract submission now open for the Global Hepatitis Summit global-hepatitis.com #GHS2025

Architect chosen to design Fleming Initiative’s inaugural Centre | Imperial News | Imperial College London The Royal Institute of British Architects (RIBA) has announced the architect selected to design the inaugural Fleming Centre.

The Royal Institute of British Architects (RIBA) has announced the architect selected to design the inaugural Fleming Centre 🏗️

Architectural firm Stanton Williams was chosen from a shortlist for its winning concept. They will now begin work on a detailed design.

www.imperial.ac.uk/news/259753/...

New MHRA Chair Anthony Harnden outlines priorities as he starts role Professor Anthony Harnden has officially started his role as Chair of the Medicines and Healthcare products Regulatory Agency (MHRA).

Delighted to welcome Professor Anthony Harnden as our new Chair at the MHRA. bit.ly/3VX4TMX